Compare STTK & PKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STTK | PKE |
|---|---|---|
| Founded | 2016 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 538.3M | 635.0M |
| IPO Year | 2020 | 1994 |
| Metric | STTK | PKE |
|---|---|---|
| Price | $4.18 | $35.91 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 860.8K | 266.9K |
| Earning Date | 05-01-2026 | 05-15-2026 |
| Dividend Yield | N/A | ★ 1.53% |
| EPS Growth | 53.02 | ★ 93.10 |
| EPS | N/A | ★ 0.56 |
| Revenue | ★ $1,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $59.98 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.71 | $13.53 |
| 52 Week High | $8.33 | $38.20 |
| Indicator | STTK | PKE |
|---|---|---|
| Relative Strength Index (RSI) | 28.36 | 58.15 |
| Support Level | $3.67 | $31.27 |
| Resistance Level | $4.23 | $38.20 |
| Average True Range (ATR) | 0.51 | 2.10 |
| MACD | -0.15 | 0.03 |
| Stochastic Oscillator | 27.29 | 71.79 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.